title: Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
authors.forename: F
authors.initials: F
authors.lastname: Rollot
authors.forename: P
authors.initials: P
authors.lastname: Bossi
authors.forename: R
authors.initials: R
authors.lastname: Tubiana
authors.forename: E
authors.initials: E
authors.lastname: Caumes
authors.forename: V
authors.initials: V
authors.lastname: Zeller
authors.forename: C
authors.initials: C
authors.lastname: Katlama
authors.forename: F
authors.initials: F
authors.lastname: Bricaire
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control*; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003453:Cryptococcosis / Q000188:drug therapy / Q000517:prevention & control*; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D008297:Male
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine